{
  "report_rows": [
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.40B vs. cons $4.442B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$580M vs. cons $598M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Book-to-Bill (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~1.05x vs. cons 1.02x",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Revenue (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide $18.0-18.4B vs. cons $18.255B",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Non-GAAP EPS (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide $12.10-12.50 vs. cons $12.31",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Adj. EBITDA Margin (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide mid-13s vs. cons ~13.6%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 Re-acceleration Tone (qualitative)",
      "prediction": "UNCHANGED",
      "answer": "reaffirmed but caveated on investment step-up",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -6.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -9.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH - sell side trims Q3/Q4 on margin miss and H2 math skepticism; short covering provides partial cushion but does not reverse direction",
  "day5_confidence": "MEDIUM"
}